Hubbry Logo
Allergic contact dermatitisAllergic contact dermatitisMain
Open search
Allergic contact dermatitis
Community hub
Allergic contact dermatitis
logo
8 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Allergic contact dermatitis
Allergic contact dermatitis
Allergic contact dermatitis
View on Wikipedia
from Wikipedia

Allergic contact dermatitis
Illustration of allergic contact dermatitis
SpecialtyDermatology, immunology

Allergic contact dermatitis (ACD) is a form of contact dermatitis that is the manifestation of an allergic response caused by contact with a substance; the other type being irritant contact dermatitis (ICD).

Although less common than ICD, ACD is accepted to be the most prevalent form of immunotoxicity found in humans.[1] By its allergic nature, this form of contact dermatitis is a hypersensitive reaction that is atypical within the population. The mechanisms by which these reactions occur are complex, with many levels of fine control. Their immunology centres on the interaction of immunoregulatory cytokines and discrete subpopulations of T lymphocytes.

Signs and symptoms

[edit]

The symptoms of allergic contact dermatitis are very similar to the ones caused by irritant contact dermatitis, which makes the first even harder to diagnose. The first sign of allergic contact dermatitis is the presence of the rash or skin lesion at the site of exposure.[2] Depending on the type of allergen causing it, the rash can ooze, drain or crust and it can become raw, scaled or thickened. Also, it is possible that the skin lesion does not take the form of a rash but it may include papules, blisters, vesicles or even a simple red area. The main difference between the rash caused by allergic contact dermatitis and the one caused by irritant contact dermatitis is that the latter tends to be confined to the area where the trigger touched the skin, whereas in allergic contact dermatitis the rash is more likely to be more widespread on the skin.[3][failed verification] Another characteristic of the allergic contact dermatitis rash is that it usually appears after a day or two after exposure to the allergen, unlike irritant contact dermatitis that appears immediately after the contact with the trigger.

Other symptoms may include itching, skin redness or inflammation, localized swelling and the area may become more tender or warmer. If left untreated, the skin may darken and become leathery and cracked.[4] Pain can also be present. Dermatitis can occur anywhere on the skin, but is most common on the hands (22% of people), scattered across the body (18%), or on the face (17%).[5]

The rash and other symptoms typically occur 24 to 48 hours after the exposure; in some cases, the rash may persist for weeks.[2] Once an individual has developed a skin reaction to a certain substance it is most likely that they will have it for the rest of their life, and the symptoms will reappear when in contact with the allergen.

Cause

[edit]

Common allergens implicated include the following:

  • Bacitracin – topical antibiotic found by itself, or as Polysporin or Triple Antibiotic
  • Balsam of Peru (Myroxylon pereirae) – used in food and drink for flavoring, in perfumes and toiletries for fragrance, and in medicine and pharmaceutical items for healing properties; derived from tree resin.[6][7][8] It may also be a component of artificial vanilla and/or cinnamon flavorings.[6]
  • Chromium – used in the tanning of leather. Also a component of uncured cement/mortar, facial cosmetics and some bar soaps.
  • Cobalt chloride – metal found in medical products; hair dye; antiperspirant; metal-plated objects such as snaps, buttons or tools; and in cobalt blue pigment
  • Colophony (Rosin) – rosin, sap or sawdust typically from spruce or fir trees
  • Formaldehyde – preservative with multiple uses, e.g., in paper products, paints, medications, household cleaners, cosmetic products, and fabric finishes. Often released into products by the use of formaldehyde releasers such as imidazolidinyl urea, diazolidinyl urea, Quaternium-15, DMDM Hydantoin, and 2-bromo-2-nitropropane-1,3-diol.
  • Fragrance mix – group of the eight most common fragrance allergens found in foods, cosmetic products, insecticides, antiseptics, soaps, perfumes, and dental products [9]
  • Gold (gold sodium thiosulfate) – precious metal and compound often found in jewelry and dental materials
  • Isothiazolinones – preservatives used in many personal care, household, and commercial products.
  • Mercaptobenzothiazole – in rubber products, notably shoes, gloves, and car tires.
  • Neomycin – topical antibiotic common in first aid creams and ointments, cosmetics, deodorant, soap, and pet food. Found by itself, or in Neosporin or Triple Antibiotic
  • Nickel (nickel sulfate hexahydrate) – has been recognized as a significant cause of allergy.[10] This metal is frequently encountered in stainless steel cookware,[11] jewelry and clasps or buttons on clothing. Current estimates gauge are that roughly 2.5 million US adults and 250,000 children suffer from nickel allergy, which costs an estimated $5.7 billion per year for treatment of symptoms.[12] A significant portion of nickel allergy is preventable.[13]
  • p-Phenylenediamine (PPD) – although it's mainly used as a component of engineering polymers and composites like kevlar, it is also an ingredient in hair dyes which once sensitized to, becomes lifelong. One can develop active sensitization to products, including but not limited to black clothing, various inks, hair dye, dyed fur, dyed leather, and certain photographic products.
  • Photographic developers, especially those containing metol
  • Quaternium-15 – preservative in cosmetic products (self-tanners, shampoo, nail polish, sunscreen) and in industrial products (polishes, paints and waxes).[14]
  • Sap from certain species of mangrove and agave
  • Soluble salts of platinum – see platinosis
  • Thiomersal – mercury compound used in local antiseptics and in vaccines
  • Topical anesthetics – such as pramoxine or diphenhydramine, after prolonged use
  • Topical steroid – see steroid allergy
  • Urushiol – oily coating from plants of Toxicodendron genus – poison ivy, poison oak, and poison sumac. Also found in mango plants, mango skin, cashews, and smoke from burning urushiol-containing plants, which can cause skin as well as severe lung irritation.

Mechanism

[edit]

Allergic contact dermatitis (ACD) arises as a result of two essential stages: an induction phase, which primes and sensitizes the immune system for an allergic response, and an elicitation phase, in which this response is triggered.[1] During the induction phase, exposure to the allergic substance (allergen) leads to its processing and presentation by immune cells, priming the immune system for a response. In the elicitation phase, subsequent contact with the same allergen, T cells directly recognize the allergen resulting in an immune response at the contact site. The allergic reaction, being mediated directly by T-cells, is classified as a Type IV hypersensitivity reaction. This classification differs from the more prevalent Type I hypersensitivity (e.g., hay fever), where allergens bind to antibodies, that subsequently trigger mast cells.

In contact allergies, the molecules responsible (allergens) are typically small and cannot be directly recognized by the immune system. These allergens can trigger a reaction only after they undergo a process called haptenization. During haptenization, the allergens bind to larger molecules (carrier proteins) naturally present in the skin. This complex of allergen and carrier protein is what the immune system detects as foreign, leading to an allergic response.

The conjugate formed is then recognized as a foreign body by the Langerhans cells (LCs) (and in some cases other Dendritic cells (DCs)), which then internalize the protein; transport it via the lymphatic system to the regional lymph nodes; and present the antigen to T-lymphocytes. This process is controlled by cytokines and chemokines – with tumor necrosis factor alpha (TNF-α) and certain members of the interleukin family (1, 13 and 18) – and their action serves either to promote or to inhibit the mobilization and migration of these LCs.[1] As the LCs are transported to the lymph nodes, they become differentiated and transform into DCs, which are immunostimulatory in nature.

Once within the lymph glands, the differentiated DCs present the allergenic epitope associated with the allergen to T lymphocytes. These T cells then divide and differentiate, clonally multiplying so that if the allergen is experienced again by the individual, these T cells will respond more quickly and more aggressively.

White et al. have suggested that there appears to be a threshold to the mechanisms of allergic sensitization by ACD-associated allergens (1986).[15] This is thought to be linked to the level at which the toxin induces the up-regulation of the required mandatory cytokines and chemokines. It has also been proposed that the vehicle in which the allergen reaches the skin could take some responsibility in the sensitization of the epidermis by both assisting the percutaneous penetration and causing some form of trauma and mobilization of cytokines itself.

Memory response

[edit]

Once an individual is sensitized to an allergen, future contacts with the allergen can trigger a reaction, commonly known as a memory response, in the original site of sensitization. So for example if a person has an allergic contact dermatitis on the eyelids, say from use of makeup, touching the contact allergen with the fingers can trigger an allergic reaction on the eyelids.[citation needed]

This is due to local skin memory T-cells, which remain in the original sensitization site. In a similar fashion, cytotoxic T lymphocytes patrol an area of skin and play an important role in controlling both the reactivation of viruses (such as the "cold sore" virus) and in limiting its replication when reactivated.[16] Memory response, or "Retest Reactivity", usually takes 2 to 3 days after coming in contact with the allergen, and can persist for 2 to 4 weeks.

Diagnosis

[edit]

Diagnosing allergic contact dermatitis is primarily based on physical exam and medical history. In some cases doctors can establish an accurate diagnosis based on the symptoms that the patient experiences and on the rash's appearance. In the case of a single episode of allergic contact dermatitis, this is all that is necessary. Chronic and/or intermittent rashes which are not readily explained by history and physical exam often will benefit from further testing.

Patch test

A patch test (contact delayed hypersensitivity allergy test)[17] is a commonly used examination to determine the exact cause of an allergic contact dermatitis. According to the American Academy of Allergy, Asthma, and Immunology, "patch testing is the gold standard for contact allergen identification".[2]

The patch test consists of applying small quantities of potential allergens to small patches which are then placed on the skin.[18] After two days, they are removed and if a skin reaction occurred to one of the substances applied, a raised bump will be noticeable underneath the patch. The tests are again read at 72 or 96 hours after application.

Patch testing is used for patients who have chronic, recurring contact dermatitis.[2] Other tests that may be used to diagnose contact dermatitis and rule out other potential causes of the symptoms include a skin biopsy and culture of the skin lesion.

Treatment

[edit]

The clinical expression of the dermatitis can be mitigated by avoidance of the allergen. Through compliance with avoidance measures, the immune system can become less stimulated. The key to avoidance is proper evaluation and detection of the inciting allergen. However, once the immune system registers the allergen, the recognition is usually permanent.

The first step in treating the condition is appropriate recognition of the clinical problem, followed by identification of the culprit chemical and the source of that chemical. Corticosteroid creams should be used carefully and according to the prescribed directions because when overused over longer periods of time they can cause thinning of the skin. Also, in some instances such as poison ivy dermatitis calamine lotion and cool oatmeal baths may relieve itching.[19]

Unlike the more common Type I allergies (e.g. hay fever), contact allergies are not mediated by histamine, making the use of normal allergy medication (antihistamine) medication ineffective and other drugs have to be used to treat the allergic reaction.

Usually, severe cases are treated with systemic corticosteroids which may be tapered gradually, with various dosing schedules ranging from a total of 12 – 20 days to prevent the recurrence of the rash (while the chemical allergen is still in the skin, up to 3 weeks, as well as a topical corticosteroid.[2] Tacrolimus ointment or pimecrolimus cream can also be used additionally to the corticosteroid creams or instead of these. Oral antihistamines such as diphenhydramine or hydroxyzine may also be used in more severe cases to relieve the intense itching via sedation.[20] Topical antihistamines are not advised as there might be a second skin reaction (treatment associated contact dermatitis) from the lotion itself.

The other symptoms caused by allergic contact dermatitis may be eased with cool compresses to stop the itching. It is vital for treatment success that the trigger be identified and avoided. The discomfort caused by the symptoms may be relieved by wearing smooth-textured cotton clothing to avoid frictional skin irritation or by avoiding soaps with perfumes and dyes. Commonly, the symptoms may resolve without treatment in 2 to 4 weeks but specific medication may hasten the healing as long as the trigger is avoided. Also, the condition might become chronic if the allergen is not detected and avoided.

Identification of the allergen can be aided by the site of the dermatitis. Allergic dermatitis of the hands is often due to contact with preservatives, fragrances, metals, rubber, or topical antibiotics.[5] Dermatitis at the front of the face is often due to gold (from jewelry and foundation), make-up, moisturizers, wrinkle creams, and topical medication.[5] Along the eyelids as well as the sides of the head and neck, dermatitis is often caused by shampoo and conditioner dripping down from the hair.[5] Inflammation on one side of the face often suggests transfer of an allergen from the hands or from the face of a partner.[5]

Epidemiology

[edit]

Allergic contact dermatitis is common, affecting up to 20% of all people.[5] People sensitive to one allergen are at an increased risk of being sensitive to others.[5] Family members of those with allergic contact dermatitis are at higher risk of developing it themselves.[5] Women are at higher risk of developing allergic contact dermatitis than men.[5]

See also

[edit]

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Allergic contact dermatitis

View on Grokipedia
from Grokipedia
Allergic contact dermatitis (ACD) is a common inflammatory disorder caused by a delayed ( reaction to environmental allergens that penetrate the and trigger an in previously sensitized individuals. This T-cell-mediated process leads to an eczematous rash typically appearing 24 to 72 hours after exposure, distinguishing it from immediate reactions. ACD is not contagious and affects people of all ages, with a prevalence of contact allergy estimated at around 20% in the general population across various regions, though symptomatic cases occur less frequently at 1.7% to 9.8%. The condition arises from direct contact with haptens—small molecules that become immunogenic when bound to proteins—such as metals like (a leading cause), fragrances, rubber accelerators, preservatives (e.g., formaldehyde releasers, including recently highlighted sulfites as the 2024 American Contact Dermatitis Society Allergen of the Year), and plant oleoresins from or . Occupational exposures, including in healthcare, hairdressing, and construction, increase risk, as do factors like impaired barrier function from or frequent wet work. Sensitization typically requires prior exposure, after which even trace amounts can provoke recurrence, with common sites including hands, face, and eyelids due to transfer or airborne allergens. Clinically, ACD manifests as pruritic, erythematous patches or plaques, often with vesicles, bullae, or scaling confined to the contact area, though id reactions (widespread dissemination) can occur in severe cases. Symptoms vary by allergen potency and exposure duration but generally resolve within 2-4 weeks if the trigger is removed, though chronic exposure may lead to lichenification or secondary infections. Diagnosis relies on a detailed history of exposures, , and confirmatory patch testing, where standardized are applied under occlusion for 48 hours and read at 48-96 hours to detect delayed reactions. Effective management centers on identifying and avoiding the culprit through and lifestyle adjustments, supplemented by barrier protection like gloves for high-risk activities. Symptomatic relief includes emollients to restore the skin barrier and topical corticosteroids (e.g., mid- to high-potency for acute lesions) applied twice daily for 1-2 weeks; severe or widespread cases may require short courses of oral corticosteroids tapered over 2-3 weeks. Antihistamines can help control itching, and inhibitors like are alternatives for sensitive areas such as the face. is excellent with avoidance, though lifelong vigilance is often necessary due to persistent sensitization.

Definition and Classification

Definition

Allergic contact dermatitis is an inflammatory skin disorder resulting from a type IV (delayed) reaction, characterized by a T-cell-mediated to environmental haptens—small, reactive molecules that penetrate the and conjugate with skin proteins to form immunogenic complexes. This adaptive immune activation occurs only in previously sensitized individuals, distinguishing it as an acquired allergic phenomenon rather than an innate response. Clinically, the condition features a delayed onset, with symptoms emerging 24 to 72 hours after re-exposure to the sensitizing agent, manifesting as an acute or chronic eczematous confined initially to the site of contact but capable of spreading to adjacent or distant areas through mechanisms like autoeczematization. The typically includes , vesicles, , and pruritus, reflecting localized T-lymphocyte infiltration and release that perpetuate tissue damage. This pathology exemplifies a maladaptive deployment of the , wherein evolutionary safeguards against pathogens erroneously target harmless haptens, culminating in self-perpetuating cutaneous inflammation and impaired barrier function.

Distinction from Other Dermatitides

Allergic contact dermatitis (ACD) is distinguished from other dermatitides primarily by its immune-mediated mechanism involving type IV delayed , in contrast to non-immune or immediate reactions seen in related conditions. Unlike (ICD), which results from direct cytotoxic damage to the skin barrier without prior and typically manifests within hours of exposure, ACD requires an initial sensitization phase and elicits symptoms 24 to 72 hours after re-exposure to the . ICD often affects a larger proportion of the due to its non-specific nature, while ACD is limited to sensitized individuals and may spread beyond the initial contact site. In comparison to , which is a chronic, genetically influenced inflammatory disorder driven by a defective barrier and Th2-dominated immune responses without a specific external contact trigger, ACD arises acutely from identifiable haptens and involves Th1/Th17 pathways. commonly presents in flexural areas with persistent pruritus, whereas ACD is episodic and confined to areas of exposure, though overlap can occur in atopics due to enhanced penetration. Photocontact dermatitis variants further highlight distinctions: photoallergic contact dermatitis, a subtype of , involves UV light activation of haptens into immunogenic compounds leading to delayed reactions, differing from phototoxic reactions that cause immediate, non-immune irritation similar to but exacerbated by sunlight. Urticarial reactions, such as contact urticaria, are immediate mediated by IgE and mast cells, producing transient wheals and flares within minutes, in opposition to the eczematous, delayed morphology of . A defining diagnostic feature of ACD is the positive , which reproduces the reaction in sensitized individuals but remains negative in ICD, , or urticarial cases, confirming the allergic .
ConditionMechanismOnsetKey FeaturesDiagnostic Test
Allergic Contact DermatitisType IV T-cell mediatedDelayed (24-72 hours)Eczematous at contact site, spreads in sensitized individualsPositive
Irritant Contact DermatitisNon-immune, direct toxicityImmediate (hours)Localized irritation, dose-dependent, no Negative
Genetic/Th2 immune dysregulationChronicFlexural distribution, persistent without specific triggerClinical history, no specificity
Photoallergic DermatitisUV-activated type IVDelayed (24-48 hours post-exposure) in sun-exposed areasPhotopatch testing
Contact UrticariaType I IgE-mediatedImmediate (minutes)Wheals and flaresPrick or use testing

Clinical Presentation

Signs

Allergic contact dermatitis manifests primarily through visible changes at the site of exposure, beginning with erythematous papules that form on an inflamed base. These papules may evolve into vesicles and bullae, particularly in acute presentations, where fluid-filled blisters contribute to the characteristic appearance. Vesicular eruptions on the fingertips are characteristic in hand allergic contact dermatitis, particularly from additives in disinfectants such as quaternary ammonium compounds (e.g., benzalkonium chloride) or preservatives like methylisothiazolinone rather than alcohol itself, commonly seen in healthcare workers due to frequent exposure. Scaling and fissuring often accompany these lesions, reflecting disruption of the barrier. The distribution of lesions typically mirrors the pattern of contact, aiding in clinical recognition. Linear configurations, such as streaking, are common in exposures to plants like in rhus dermatitis, where the spreads via inadvertent touch. Geometric or sharply demarcated patterns may appear with direct contact from objects, including jewelry, outlining the precise area of exposure. Asymmetric involvement is frequent, as the reaction localizes to the specific site of application rather than spreading symmetrically. Over time, the condition progresses from acute to chronic phases, altering the skin's texture and color. In the acute stage, lesions may weep and develop crusts as vesicles rupture, leading to oozing surfaces. Chronic evolution involves thickening and lichenification, with persistent scaling, fissuring, and potential at the affected sites.

Symptoms and Complications

The primary symptoms of allergic contact dermatitis are intense pruritus, which patients often describe as the most debilitating aspect, along with sensations of burning and stinging that can intensify upon contact with the , as well as a sensation of skin tension or tightness. These symptoms typically develop 24 to 72 hours after exposure and may persist or worsen without allergen avoidance. The severe itching frequently leads to sleep disturbances, as patients report difficulty resting due to nocturnal of pruritus. Complications of allergic contact dermatitis arise primarily from or ongoing and include secondary bacterial infections, such as impetiginization, which can occur when broken allows bacterial entry. Post-inflammatory or may develop after the acute phase resolves, particularly in individuals with darker tones, while severe or repeated episodes can result in scarring. Persistent exposure to the heightens the risk of chronicity, potentially triggering an (autoeczematization), where itchy, eczematous patches appear distant from the original site, or, in rare severe cases, progressing to erythroderma with widespread involvement. Allergic contact dermatitis substantially impairs , with psychological effects including anxiety and depression stemming from visible lesions, chronic discomfort, and disruption of daily activities. Studies indicate that emotional distress is a prominent feature, often more impactful than physical symptoms alone, affecting work productivity and social interactions.

Causes and Risk Factors

Common Allergens

Allergic contact dermatitis is frequently triggered by exposure to metals, which act as haptens binding to skin proteins to elicit an . sulfate is the most prevalent metal , accounting for approximately 18-24% of positive patch tests in sensitized individuals, commonly found in jewelry, coins, and clothing fasteners. and follow as significant sensitizers, with cobalt often co-reacting with nickel in metal alloys, while gold sensitivity arises from prolonged contact with dental appliances or jewelry. , particularly , is a key occupational in construction, present in and tanning processes. Fragrances and preservatives represent another major category of allergens in consumer products. Fragrance mixes, comprising compounds like cinnamal and , are detected in 10-15% of patch-tested patients and are ubiquitous in perfumes, soaps, and lotions. Preservatives such as formaldehyde releasers (e.g., ) and isothiazolinones (e.g., ) are common in and personal care items, with sensitivity linked to textiles and adhesives as well. Rubber accelerators, including thiurams and carbamates in carba mix, cause reactions in 10-12% of cases, primarily from gloves, , and elastic fabrics. Disinfectants, widely used in healthcare and other occupational settings, can trigger allergic contact dermatitis through additives such as quaternary ammonium compounds (e.g., benzalkonium chloride) and preservatives including methylisothiazolinone, rather than alcohol in alcohol-based products. These reactions commonly affect the hands, often presenting with fingertip involvement including blistering, and are a significant concern among healthcare workers due to repeated exposure during hand hygiene and surface cleaning. Plants containing , an oleoresin in species like (Toxicodendron radicans), , and poison sumac, are responsible for the majority of naturally occurring allergic contact dermatitis cases in , affecting up to 85-90% of the population upon exposure. Urushiol penetrates the skin from damaged plant parts, leading to characteristic linear vesicles. Occupational exposures heighten risk in certain professions; for instance, chromate in wet cement induces hand dermatitis in construction workers, while paraphenylenediamine (PPD) in hair dyes sensitizes beauticians and users, comprising up to 5-10% of relevant allergies in these groups. In healthcare, quaternary ammonium compounds in disinfectants contribute to hand dermatitis in workers with repeated exposure. In consumer products, often harbor multiple allergens, including fragrances, preservatives, and PPD in dyes, with neomycin in topical antibiotics like ointments causing iatrogenic in 5-10% of treated patients. Textiles contribute through dyes, resins, and rubber components, exacerbating chronic hand or leg . Emerging allergens have gained prominence since the , notably acrylates in artificial nail products, which provoke severe periungual reactions in salon workers and consumers, and isothiazolinones in water-based paints, household cleaners, and disinfectants, driving a surge in reported cases due to increased use and inadequate labeling.

Predisposing Factors

Genetic factors play a significant role in susceptibility to allergic contact dermatitis, particularly through mutations in the gene (FLG), which encodes a protein essential for maintaining the skin's barrier function. Loss-of-function mutations in FLG lead to impaired epidermal barrier integrity, increasing the penetration of allergens and thereby elevating the risk of sensitization and development of allergic contact dermatitis. These mutations are also associated with chronic involving combined allergic and irritant components. An atopic background further predisposes individuals to allergic contact dermatitis, as those with exhibit higher rates of contact sensitization due to inherent skin barrier defects and increased allergen exposure from frequent topical treatments. Patients diagnosed with allergic contact dermatitis show significantly increased odds of concurrent eczema and other atopic conditions, such as , compared to the general population. Age and sex influence the prevalence of allergic contact dermatitis, with higher rates observed in females, often attributed to greater exposure to cosmetics and jewelry containing common allergens. The condition typically peaks in incidence among adults aged 20 to 50 years, reflecting cumulative environmental exposures during these active decades. Disruption of the skin barrier, such as from prior damage or chronic conditions, heightens vulnerability to allergic contact dermatitis by facilitating penetration into the . For instance, patients with leg ulcers or face an elevated risk due to the loss of the protective epidermal layer, allowing topical agents applied to wounds to trigger . Chronic nonhealing wounds exacerbate this by prolonging exposure to potential allergens in dressings and medications. Occupational exposures represent a key predisposing factor, with allergic contact dermatitis accounting for approximately 20% of occupational cases overall. Healthcare workers are particularly at risk from frequent glove use and exposure to disinfectants, where accelerators in rubber gloves and quaternary ammonium compounds can cause sensitization, with latex hypersensitivity incidence reaching up to 9.6% in this group. Florists experience high prevalence due to plant handling, with hand dermatitis reported in 8% to 46% of workers, often involving allergic reactions to floral s. In certain high-risk trades like healthcare and , prevalence rates range from 10% to 15%, underscoring the impact of repeated irritant and contact.

Pathophysiology

Sensitization Phase

The sensitization phase of allergic contact dermatitis represents the initial, asymptomatic priming of the upon first exposure to a , a small molecular weight chemical (typically <500 Da) that is immunologically inert alone but becomes antigenic when modified. penetrate the , the outermost layer of the , often facilitated by compromised or the chemical's , allowing access to viable epidermal layers. Once in the , the hapten covalently binds to endogenous proteins—such as , , or other structural components—forming a complete immunogenic complex known as a hapten-protein conjugate or complete . This haptenation process is a critical key event, as it alters the protein's structure to render it recognizable by the , typically through electrophilic reactions that form stable adducts. The hapten-protein complexes are primarily captured by resident epidermal antigen-presenting cells, particularly Langerhans cells, which are specialized dendritic cells comprising 2-4% of epidermal cells. Langerhans cells internalize the antigens via or , process them into peptides, and load them onto (MHC) class II molecules for presentation. Activated by danger signals from (e.g., cytokines like IL-1β and TNF-α released in response to hapten-induced stress), Langerhans cells mature, upregulate co-stimulatory molecules (e.g., , ), and migrate via lymphatic vessels to the regional draining lymph nodes, a process that begins within hours and peaks at 24-48 hours post-exposure. In the lymph nodes, these antigen-bearing dendritic cells interact with naive T cells. In the paracortical regions of the lymph nodes, the presented hapten-peptide-MHC complexes engage naive CD4+ helper T cells and CD8+ cytotoxic T cells specific for the , providing signal 1 (TCR recognition). Co-stimulatory signals (signal 2) and cytokine milieu (signal 3, e.g., IL-12 for Th1 differentiation) drive T-cell activation, leading to clonal proliferation and differentiation into effector and central T cells. This generates a population of hapten-specific T cells that persist long-term in the skin and lymphoid tissues, establishing immunological without eliciting a visible skin reaction during this phase. Both CD4+ T cells (promoting Th1/Th17 responses via IFN-γ and IL-17) and CD8+ T cells (contributing cytotoxic functions) are involved, though their relative roles can vary by allergen. The entire sensitization process is typically and requires 10-15 days to fully develop, during which no clinical occurs despite the initial contact. This phase exemplifies , a cell-mediated response orchestrated by T cells.

Elicitation Phase

Upon re-exposure to the in a previously sensitized individual, the elicitation phase of allergic contact dermatitis is triggered as hapten-specific memory T cells, primarily + effector T cells, recognize the presented by resident antigen-presenting cells such as Langerhans cells. These memory T cells rapidly proliferate and release pro-inflammatory cytokines, including interferon-gamma (IFN-γ) and interleukin-17 (IL-17), which orchestrate the recruitment of additional inflammatory cells like neutrophils, , and monocytes to the site of contact. This cytokine-mediated response amplifies the local immune reaction, leading to the characteristic inflammatory dermatitis. In the epidermis, the influx of activated T cells results in key histopathological changes, including (intercellular ), exocytosis of lymphocytes into the epidermal layers, and the formation of intraepidermal vesicles filled with . These alterations disrupt the epidermal barrier and contribute to the clinical manifestations of , , and vesiculation observed in affected . The inflammatory cascade is further amplified by innate immune cells, with natural killer (NK) cells modulating T cell cluster formation and enhancing the response, while macrophages polarize toward pro-inflammatory phenotypes to sustain production and tissue damage. The severity of the reaction exhibits a dose-dependent threshold, where higher concentrations lower the minimal eliciting dose required to provoke clinical symptoms, influenced by prior sensitization intensity. Clinically, symptoms typically emerge 24 to 72 hours after re-exposure due to the delayed mechanism, peaking around 72 to 96 hours, with spontaneous resolution occurring in 2 to 3 weeks if avoidance is maintained and no secondary infection develops.

Diagnosis

Clinical Assessment

The clinical assessment of suspected allergic contact dermatitis begins with a thorough history to elucidate potential exposures and timelines. Clinicians inquire about the onset and progression of symptoms relative to recent or recurrent contacts, including occupational hazards (e.g., chemicals in or healthcare), hobbies (e.g., or crafting), and daily product use such as , soaps, or metals in jewelry. is crucial; for instance, periorbital or involvement may indicate inadvertent transfer of allergens like or fragrances from hand contact to the face. During the physical examination, emphasis is placed on correlating lesion distribution with likely contact sites, such as hands for occupational exposures or ears/ for jewelry allergens. Acute presentations often feature well-demarcated, erythematous patches with vesicles, bullae, or oozing in exposed areas, reflecting an inflammatory response. In contrast, chronic or recurrent cases show thickened, lichenified skin with scaling and fissuring due to repeated and . These morphological features, combined with the geometric or localized (e.g., linear streaks from Rhus plants), help distinguish allergic from other dermatoses. Differential diagnosis requires careful consideration to exclude mimics like (which lacks prior sensitization and often affects broader areas immediately), endogenous conditions such as atopic or nummular eczema (typically symmetric and not strictly contact-related), and infections including or bacterial (which may show pustules or annular patterns). History and exam findings guide this process, prioritizing exposures over genetic or idiopathic factors in endogenous cases. Red flags warranting further evaluation include systemic symptoms such as fever, , or generalized eruptions, which may indicate alternative diagnoses like drug-induced eruptions, , or even cutaneous rather than isolated allergic contact dermatitis. In such scenarios, the absence of clear contact patterns or rapid dissemination beyond exposure sites raises suspicion for non-allergic etiologies.

Patch Testing and Other Tests

Patch testing serves as the gold standard diagnostic procedure for confirming allergic contact dermatitis by identifying specific allergens responsible for reactions. Standardized allergen panels, such as the TRUE Test, which contains 35 common contact including nickel sulfate, fragrance mix, and preservatives, are applied to the patient's upper back using adhesive strips. These patches are secured and left in place for 48 hours to allow penetration into the , mimicking natural exposure conditions. Initial readings occur approximately 48 hours after application (day 2), with a second reading at 96 hours (day 4) to capture peak delayed responses, as reactions may intensify or appear later. Reactions are graded according to the International Research Group (ICDRG) scale to standardize interpretation: a doubtful reaction (?) shows faint macular without infiltration; 1+ indicates a weak positive with non-vesicular , papules, or slight infiltration; 2+ denotes a strong positive with vesicles, , or pronounced infiltration; and 3+ represents an extreme positive with coalescing vesicles, bullae, or ulceration. A positive reaction (1+ to 3+) signifies , meaning the patient's has developed memory T-cell responses to the upon prior exposure. However, differentiation from irritant reactions—such as discrete without induration—is crucial, as false positives can arise from primary , over-application of allergens, or "angry back" where adjacent reactions amplify nearby sites. False negatives may occur if the allergen concentration is suboptimal, the patient is on topical corticosteroids or systemic immunosuppressants, or if the test site is compromised by active . Alternative diagnostic approaches are limited and typically supplementary. Intradermal testing, involving injection of dilute allergens into the , is rarely employed due to risks of systemic or exaggerated local responses and is not recommended for routine use in . Chemical analysis of patient products, such as the dimethylglyoxime spot test for detecting releasable ions in metals (positive if pink-red color develops), helps verify exposure but does not assess . Skin , while useful to rule out other conditions, reveals non-specific features like epidermal (intercellular ) and perivascular lymphocytic infiltrates in the elicitation phase, lacking diagnostic specificity for without correlating clinical history. Despite its utility, patch testing has notable limitations, primarily that a positive result confirms but does not guarantee clinical relevance, as up to 50% of positives may not correlate with the patient's due to or irrelevant exposures. It also cannot test all potential allergens, particularly occupation-specific ones, requiring supplemental panels. Emerging , such as the lymphocyte transformation test (LTT), provide alternatives by culturing patient peripheral blood mononuclear cells with suspected allergens like and measuring T-cell proliferation via tritiated thymidine incorporation or ; this approach avoids skin irritation and shows sensitivity of 70-90% for metal allergies, though it remains research-oriented and not widely standardized for clinical practice. Patch tests commonly screen for allergens like those in the North American Group series, but customization may be needed based on exposure history.

Treatment and Management

Avoidance Strategies

The cornerstone of managing allergic contact dermatitis involves identifying the responsible through patch testing and implementing strict avoidance measures to prevent recurrence. Once allergens are confirmed, patients are advised to meticulously read product labels to detect ingredients such as in jewelry or fragrances in , thereby eliminating exposure sources. Hypoallergenic alternatives play a crucial role in daily life; for instance, opting for nickel-free jewelry or accessories coated with materials reduces the risk of in susceptible individuals. Similarly, product substitution strategies include selecting fragrance-free and personal care items, as well as powder-free gloves for those with rubber accelerator allergies, to minimize inadvertent contact. Patient education is essential for long-term success, emphasizing recognition of hidden exposures and potential cross-reactivities. For example, individuals allergic to —a common fragrance component—should avoid not only perfumed products but also related substances like certain spices, flavors, or topical medications containing chemically similar resins to prevent flares. Ongoing monitoring supports adherence, with tools such as the Contact Allergen Management Program (CAMP) database enabling patients to generate personalized lists of safe household and based on their specific allergens. Regular follow-up consultations confirm the of identified allergens and adjust avoidance plans as needed.

Pharmacological Interventions

Topical corticosteroids represent the cornerstone of pharmacological management for allergic contact dermatitis, effectively reducing inflammation, erythema, and pruritus in most cases. Potency selection is guided by lesion location and severity: super-high-potency agents (Class I, such as clobetasol propionate 0.05%) are preferred for thick-skinned areas like the palms and soles, while mid-potency (Class III-IV, e.g., triamcinolone acetonide 0.1%) or low-potency (Class VI-VII, e.g., hydrocortisone 1%) formulations are suitable for acute localized lesions or thinner skin to minimize risks. Treatment duration is typically limited to 1-2 weeks to prevent adverse effects such as skin atrophy, telangiectasia, or striae, with intermittent or pulse dosing considered for chronic maintenance. For sensitive areas like the face, eyelids, or regions where corticosteroid-induced is a concern, topical calcineurin inhibitors such as 0.1% ointment offer a steroid-sparing alternative by inhibiting T-cell activation and release. These agents are particularly useful in refractory or persistent cases, such as - or preservative-induced , with studies demonstrating clinical improvement within 1-4 weeks and good tolerability, though initial burning may occur. In widespread or severe allergic contact dermatitis involving more than 20% of , systemic corticosteroids like (0.5-1 mg/kg/day orally) provide rapid relief, often within 12-24 hours, but should be administered as a short course with gradual tapering over 2-3 weeks to prevent rebound flares or adrenal suppression. For refractory cases unresponsive to topical therapies, immunosuppressants such as cyclosporine (3-5 mg/kg/day orally) may be employed under specialist supervision, yielding improvement in severe presentations but requiring monitoring for and due to limited long-term data in this context. Emerging therapies for recalcitrant allergic contact dermatitis include biologics such as , an IL-4/IL-13 inhibitor approved for but showing efficacy in case series for severe ACD unresponsive to standard treatments, with improvements noted in 4-12 weeks under dermatologist oversight. Oral Janus kinase (JAK) inhibitors like or have also demonstrated promise in small studies for chronic cases, targeting inflammatory pathways, though long-term safety data specific to ACD remain limited as of 2025. Adjunctive therapies support symptom control and skin integrity; emollients (e.g., petrolatum-based ointments) aid barrier repair and hydration, especially in chronic or dry lesions, reducing without pharmacological risks. Oral antihistamines, such as hydroxyzine or diphenhydramine, offer limited relief for pruritus primarily through effects to improve , but lack direct benefits in allergic contact dermatitis. If secondary bacterial infection complicates lesions, short-term topical or systemic antibiotics may be added, though this is not routine.

Prevention

Personal Prevention Measures

Individuals can prevent allergic contact dermatitis by adopting routines that maintain the skin's and minimize exposure to potential allergens. Regular application of emollients or moisturizers helps restore and protect the skin's outer layer, reducing the risk of sensitization, particularly in those with compromised barriers such as individuals with . After potential exposure to irritants or allergens, thorough washing with mild, fragrance-free and lukewarm removes residues and prevents penetration into the skin. Barrier creams, such as those containing dimethicone or specific formulations like bentoquatam for urushiol-containing plants, can provide a protective layer against known allergens when applied prior to exposure. Choosing products is essential for reducing the likelihood of reactions from , personal care items, and jewelry. Opt for items labeled fragrance-free and certified , as these are formulated to minimize common allergens like preservatives and metals, though "" claims should be verified for substantiation. If history suggests sensitivity, consulting a dermatologist for formal patch testing is recommended. In cases of known metal allergies, such as to , selecting surgical-grade , 14- or 18-karat gold, or for jewelry and piercings avoids elicitation. Lifestyle adjustments further support prevention by limiting direct contact with allergens. Wearing protective clothing, including gloves, long sleeves, and pants, shields the skin during activities involving potential irritants like or household chemicals. Once personal allergens are identified through prior testing, strict avoidance—such as substituting latex-free gloves or nickel-free accessories—prevents both and elicitation phases. For example, covering metal fasteners on with iron-on patches can block allergen transfer. Education is particularly important for at-risk groups, such as children with , where proactive emollient use from early infancy can enhance skin barrier integrity and lower the incidence of atopic conditions that predispose to contact allergies. Parents should be advised to apply fragrance-free emollients daily to affected areas, avoiding known personal triggers like certain fabrics or dyes, to prevent secondary allergic contact dermatitis. 01118-X/fulltext)

Occupational and Environmental Controls

Occupational and environmental controls play a crucial role in preventing allergic contact dermatitis (ACD) by minimizing exposure to sensitizing agents at systemic and professional levels. In workplaces, regulatory frameworks such as the Occupational Safety and Health Administration's (OSHA) Hazard Communication Standard mandate that employers develop programs to communicate information on hazardous chemicals, including skin sensitizers, through labeling, safety data sheets, and worker training to enable recognition and avoidance of potential allergens. Similarly, OSHA guidelines emphasize ventilation systems in chemical industries to capture and remove airborne contaminants that could deposit on skin surfaces, thereby reducing the risk of sensitization in sectors like manufacturing and processing. Engineering controls prioritize the substitution of hazardous materials with safer alternatives to eliminate or reduce exposure. For instance, in the construction industry, replacing traditional containing with low-chromium or non-chromated formulations has significantly lowered ACD incidence among workers handling wet cement. Other engineering measures include process enclosures, isolation booths for spraying operations, and automated handling systems to prevent direct skin contact with irritants or s in high-exposure environments such as laboratories and production lines. When substitution is not feasible, (PPE) like chemical-resistant gloves, aprons, and coveralls serves as a secondary barrier, with selection guided by compatibility testing to avoid breakthrough by specific s. Surveillance programs in high-risk occupations facilitate early detection and intervention. In fields like , where exposure to and acrylates is common, routine skin screening and patch testing when indicated are recommended as part of occupational monitoring to identify sensitized individuals and adjust exposures promptly. Hairdressers, frequently encountering paraphenylenediamine in hair dyes, benefit from similar screening protocols integrated into workplace initiatives, enabling targeted controls and reducing progression. Environmental controls extend prevention beyond workplaces to broader settings, particularly in landscaping and agriculture where plant-derived allergens pose risks. Selecting low-allergen plant species and implementing barriers such as mulching or fencing can limit worker contact with sensitizing plants like poison ivy or ragweed, while proper site planning reduces inadvertent exposure during maintenance activities. Public awareness campaigns, often led by occupational health authorities, educate communities on environmental hazards, promoting practices like vegetation management in public spaces to curb widespread sensitization from common allergens.

Epidemiology

Prevalence and Incidence

Allergic contact dermatitis (ACD) affects a significant portion of the global population, with lifetime to contact allergens estimated at 15-20% in the general population. A and of studies involving over 158,000 individuals reported a pooled of contact allergy at 20.1% (95% CI: 16.8-23.7%), reflecting widespread exposure to common environmental and consumer product allergens. However, the of clinically manifest ACD—where leads to symptomatic —is lower, with approximately 5-10% of the population experiencing episodes at least once annually.00038-8/fulltext) Annual incidence rates for new cases of ACD in the general population are estimated at 0.5-1% based on longitudinal cohort studies, though data are limited due to underreporting and diagnostic challenges. In occupational settings, where exposures are more concentrated, incidence ranges from 0.5 to 1.9 cases per 1,000 full-time workers per year. Among patients referred to dermatology clinics for suspected ACD and undergoing patch testing, positivity rates to common allergens like nickel typically range from 10-20%, with nickel eliciting positive reactions in 17-18% of tested individuals in large North American and European cohorts.32741-5/abstract) Trends indicate a rising burden of ACD, attributed to increasing chemical exposures from consumer products and industrial processes, with a notable post-2000s surge in reactions to preservatives such as and other isothiazolinones, which saw rates climb to 3-5% in patch-tested patients by the . Overall of preservative-related contact has remained stable at around 9-10% in recent years, though specific compounds like show emerging increases. Geographic variations highlight higher in industrialized regions, with European studies reporting rates of approximately 20% compared to lower figures in parts of , where rates for certain allergens like may be 10-15% in patch-tested populations, influenced by differences in product usage and regulations.

Demographic Variations

Allergic contact dermatitis exhibits notable variations by , with women experiencing a 1.5- to 2-fold higher compared to men, largely attributable to greater exposure to allergens in jewelry, , and . In contrast, men show higher rates of occupational allergic contact dermatitis from specific allergens such as chromate, which is common in and work—predominantly male-dominated fields—where sensitivity rates reach up to 6.8% in men versus 2.8% in women. Age patterns reveal that allergic contact dermatitis most frequently affects adults between 20 and 60 years old, with prevalence peaking around 40-50 years due to cumulative occupational and environmental exposures. In children and adolescents, incidence is lower but rising, particularly linked to adhesives in medical devices, tapes, and consumer products, with a noted rapid increase in cases attributed to adhesives since 2014. Ethnic considerations highlight differences in clinical presentation and reporting; individuals with darker skin types (Fitzpatrick IV-VI) more prominently develop post-inflammatory following allergic contact dermatitis reactions, which can complicate and persist longer than in lighter skin. Lower reporting rates occur in some ethnic groups, such as and populations, due to disparities in access to dermatologic care and patch testing, often resulting in delayed and prolonged disease duration. Comorbidities significantly influence allergic contact dermatitis, with approximately 50-60% overlap with , where the presence of atopic dermatitis increases the risk and severity of allergic contact reactions through impaired skin barrier function. This overlap often leads to more recalcitrant and widespread dermatitis in affected individuals.

References

  1. https://www.ncbi.nlm.nih.gov/books/NBK532866/
  2. https://www.nature.com/articles/s41572-021-00271-4
  3. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2023.1184289/full
  4. https://www.aad.org/public/diseases/eczema/types/contact-dermatitis
  5. https://nationaleczema.org/types-of-eczema/contact-dermatitis/
  6. https://pubmed.ncbi.nlm.nih.gov/39787305/
  7. https://www.mayoclinic.org/diseases-conditions/contact-dermatitis/symptoms-causes/syc-20352742
  8. https://www.aafp.org/pubs/afp/issues/2010/0801/p249.html
  9. https://www.mayoclinic.org/diseases-conditions/contact-dermatitis/diagnosis-treatment/drc-20352748
  10. https://dermnetnz.org/topics/allergic-contact-dermatitis
  11. https://dermnetnz.org/topics/contact-dermatitis
  12. https://pubmed.ncbi.nlm.nih.gov/33380932/
  13. https://www.ncbi.nlm.nih.gov/books/NBK459230/
  14. https://pmc.ncbi.nlm.nih.gov/articles/PMC6544100/
  15. https://pmc.ncbi.nlm.nih.gov/articles/PMC5948135/
  16. https://utahderm.med.utah.edu/diagnoses/contact-dermatitis/
  17. https://pubmed.ncbi.nlm.nih.gov/39652964/
  18. https://emedicine.medscape.com/article/1049216-overview
  19. https://www.merckmanuals.com/professional/dermatologic-disorders/dermatitis/contact-dermatitis
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC10319159/
  21. https://dermnetnz.org/topics/benzalkonium-chloride-contact-dermatitis
  22. https://www.actasdermo.org/en-allergic-contact-dermatitis-by-anatomical-articulo-S1578219018301744
  23. https://www.unboundmedicine.com/5minute/view/5-Minute-Clinical-Consult/116173/1.1/Dermatitis__Contact
  24. https://www.ncbi.nlm.nih.gov/books/NBK447113/
  25. https://pmc.ncbi.nlm.nih.gov/articles/PMC5465660/
  26. https://pmc.ncbi.nlm.nih.gov/articles/PMC10239928/
  27. https://pmc.ncbi.nlm.nih.gov/articles/PMC6170075/
  28. https://pmc.ncbi.nlm.nih.gov/articles/PMC8006117/
  29. https://www.ncbi.nlm.nih.gov/books/NBK557866/
  30. https://pmc.ncbi.nlm.nih.gov/articles/PMC7733371/
  31. https://pmc.ncbi.nlm.nih.gov/articles/PMC5419239/
  32. https://pmc.ncbi.nlm.nih.gov/articles/PMC8354417/
  33. https://pmc.ncbi.nlm.nih.gov/articles/PMC12552389/
  34. https://pmc.ncbi.nlm.nih.gov/articles/PMC7177224/
  35. https://pubmed.ncbi.nlm.nih.gov/18049447/
  36. https://pubmed.ncbi.nlm.nih.gov/31782153/
  37. https://pubmed.ncbi.nlm.nih.gov/19538184/
  38. https://pubmed.ncbi.nlm.nih.gov/38982608/
  39. https://pubmed.ncbi.nlm.nih.gov/38109794/
  40. https://www.researchgate.net/publication/26722052_Age-_and_sex-related_variations_in_allergic_contact_dermatitis_to_common_allergens
  41. https://www.sciencedirect.com/science/article/abs/pii/S0738081X11002239
  42. https://emedicine.medscape.com/article/1049216-clinical
  43. https://www.sciencedirect.com/science/article/pii/S2352647520301799
  44. https://pmc.ncbi.nlm.nih.gov/articles/PMC2868883/
  45. https://pmc.ncbi.nlm.nih.gov/articles/PMC10412120/
  46. https://dermnetnz.org/topics/skin-problems-in-florists
  47. https://link.springer.com/article/10.1007/s40521-022-00299-1
  48. https://pubs.acs.org/doi/10.1021/acs.chemrestox.4c00062
  49. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.00093/full
  50. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2017.00162/full
  51. https://www.sciencedirect.com/science/article/pii/S2950198925000388
  52. https://pmc.ncbi.nlm.nih.gov/articles/PMC12564274/
  53. https://www.pathologyoutlines.com/topic/skinnontumorallergiccontact.html
  54. https://pmc.ncbi.nlm.nih.gov/articles/PMC6854274/
  55. https://pubmed.ncbi.nlm.nih.gov/15350684/
  56. https://www.fda.gov/media/83084/download
  57. https://onlinelibrary.wiley.com/doi/10.1111/cod.12432
  58. https://pmc.ncbi.nlm.nih.gov/articles/PMC3900336/
  59. https://www.chemotechnique.se/patch-testing/interpretation-/
  60. https://emedicine.medscape.com/article/1049216-workup
  61. https://www.tandfonline.com/doi/full/10.2147/ccid.s3693
  62. https://www.ncbi.nlm.nih.gov/books/NBK557638/
  63. https://www.tandfonline.com/doi/full/10.3109/1547691X.2015.1008656
  64. https://karger.com/exd/article/1/2/53/133817/Diagnostic-Testing-for-Nickel-Allergic
  65. https://dermnetnz.org/topics/balsam-of-peru-allergy
  66. https://mdedge.com/cutis/article/272408/contact-dermatitis/simplifying-allergic-contact-dermatitis-management-contact-allergen-management-program-20
  67. https://emedicine.medscape.com/article/1049216-medication
  68. https://www.aafp.org/pubs/afp/issues/2021/0315/p337.html
  69. https://emedicine.medscape.com/article/1049216-treatment
  70. https://www.ncbi.nlm.nih.gov/books/NBK532940/
  71. https://pubmed.ncbi.nlm.nih.gov/12963912/
  72. https://pubmed.ncbi.nlm.nih.gov/19207676/
  73. https://pubmed.ncbi.nlm.nih.gov/30570582/
  74. https://www.jaadreviews.org/article/S2950-1989(25)00038-8/fulltext
  75. https://pubmed.ncbi.nlm.nih.gov/35856769/
  76. https://pmc.ncbi.nlm.nih.gov/articles/PMC8060671/
  77. https://www.fda.gov/cosmetics/cosmetics-labeling-claims/hypoallergenic-cosmetics
  78. https://jacionline.org/article/S0091-6749%2814%2901118-X/fulltext
  79. https://pmc.ncbi.nlm.nih.gov/articles/PMC3449106/
  80. https://www.osha.gov/otm/section-2-health-hazards/chapter-2
  81. https://www.osha.gov/sites/default/files/publications/OSHA-3351-portland-cement.pdf
  82. https://www.ccohs.ca/oshanswers/diseases/allergic_derm.html
  83. https://www.publichealthontario.ca/-/media/documents/g/2019/guide-occupational-dermatitis.pdf
  84. https://www.ccohs.ca/oshanswers/safety_haz/landscaping/poisonous_plants.html
  85. https://blogs.cdc.gov/niosh-science-blog/2022/05/04/poisonous-plants/
  86. https://pmc.ncbi.nlm.nih.gov/articles/PMC3276771/
  87. https://pubmed.ncbi.nlm.nih.gov/30370565/
  88. https://pubmed.ncbi.nlm.nih.gov/23013370/
  89. https://pubmed.ncbi.nlm.nih.gov/10592001/
  90. https://jamanetwork.com/journals/jamadermatology/fullarticle/2800343
  91. https://pubmed.ncbi.nlm.nih.gov/40443262/
  92. https://onlinelibrary.wiley.com/doi/10.1111/cod.14784
  93. https://pubmed.ncbi.nlm.nih.gov/6222873/
  94. https://pubmed.ncbi.nlm.nih.gov/11012003/
  95. https://pmc.ncbi.nlm.nih.gov/articles/PMC3391944/
  96. https://pmc.ncbi.nlm.nih.gov/articles/PMC12278594/
  97. https://pubmed.ncbi.nlm.nih.gov/31975451/
  98. https://pubmed.ncbi.nlm.nih.gov/34397351/
  99. https://pmc.ncbi.nlm.nih.gov/articles/PMC9743121/
  100. https://pubmed.ncbi.nlm.nih.gov/38151921/
Add your contribution
Related Hubs
User Avatar
No comments yet.